Therapeutic Asset Ratings
169 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Amitriptyline
Depressive Disorder, Major
Janssen Research & Development, LLC
P4
BBB
(77)
Pregabalin
Depressive Disorder, Major
Janssen Research & Development, LLC
P4
BBB
(76)
S-Ketamine
Depressive Disorder, Major
Janssen Research & Development, LLC
P4
BBB
(76)
Calcium folinate pentahydrate
Colorectal Neoplasms
Janssen Research & Development, LLC
P4
BBB
(74)
(+)-VINCRISTINE
Recurrent Adult Acute Myeloid Leukemia
Janssen Research & Development, LLC
P3
BBB
(74)
CHLORAMBUCIL
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLC
P3
BB
(71)
Ibrutinib
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC
P4
BB
(70)
((3AR,6AS)-5-(4,6-DIMETHYLPYRIMIDIN- 2-YL)HEXAHYDROPYRROLO(3,4-C)PYRROL-2(1H)-YL)(2-FLUORO- 6-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE OREXIN RECEPTOR ANTAGONIST
Depressive Disorder, Major
Janssen Research & Development, LLC
P3
BB
(70)
PREDNISONE TABLETS
Castration-Resistant Prostate Carcinoma
Janssen Research & Development, LLC
P4
BB
(69)
CIS-DIAMMINEDICHLOROPLATINUM II
Multiple Myeloma
Janssen Research & Development, LLC
P4
BB
(68)
Eloxatin
Gastrointestinal Neoplasms
Janssen Research & Development, LLC
P3
BB
(68)
Lazertinib
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
P3
BB
(68)
DARATUMUMAB
Multiple Myeloma
Janssen Research & Development, LLC
P4
BB
(67)
FILGRASTIM
Multiple Myeloma
Janssen Research & Development, LLC
P4
BB
(67)
immunoglobulin (H-gamma1_L-kappa)_scFvkh-G1(h-CH2-CH3), anti-[Homo sapiens KLK2 (kallikrein-2, kallikrein related peptidase 2, kallikrein 2 prostatic) and anti-[Homo sapiens CD3E (CD3 epsilon, Leu-4)], Homo sapiens and humanized monoclonal antibody, bispecific, bivalent
Metastatic Castration-resistant Prostate Neoplasms
Janssen Research & Development, LLC
P3
BB
(66)
Cytosin-Arabinosid
Acute Leukemia
Janssen Research & Development, LLC
P2/3
BB
(66)
Calcium folinate pentahydrate
Gastrointestinal Neoplasms
Janssen Research & Development, LLC
P3
BB
(65)
FLUOROURACILUM
Gastrointestinal Neoplasms
Janssen Research & Development, LLC
P3
BB
(65)
5-azacytidine
Myelodysplastic Syndromes
Janssen Research & Development, LLC
P3
BB
(64)
Prizloncabtagene Autoleucel
Non-Hodgkin's B-cell Lymphoma
Janssen Research & Development, LLC
P1/2
BB
(64)
DEXAMETHASONE
Acute Myeloid Leukemia
Janssen Research & Development, LLC
P4
B
(63)
Amivantamab-Vmjw
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
P3
B
(63)
Levoleucovorin
Colorectal Neoplasms
Janssen Research & Development, LLC
P3
B
(63)
5-azacytidine
Acute Myeloid Leukemia
Janssen Research & Development, LLC
P3
B
(62)
PEGASPARGASE
Leukemia, Acute
Janssen Research & Development, LLC
P2/3
B
(62)
Showing 1 to 25 of 169 assets
Previous
Page 1 of 7
Next